Drugs with this side effect as MedDRA Preferred Term
- 5-ASA
- Neutropenia: very rare, postmarketing
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- Neutropenia: very common, 2.7% - 65.7%
- A77 1726
- Anidulafungin
- BCNU
- CAS 76095-16-4
- CAS 76420-72-9
- Neutropenia: postmarketing
- Cancidas
- Carfilzomib
- Neutropenia: 0.76% - 20.7%
- Enfuvirtide
- FAMP
- FK463
- Neutropenia: 5.36% - 76.7%
- Ge-132
- Neutropenia: postmarketing
- K779
- Kaluril
- Lisinopril
- Neutropenia: very rare, postmarketing
- MDV3100
- Meropenem anhydrous
- Neutropenia: postmarketing
- Metrodin
- NSC 352122
- PCI-32765
- Romidepsin
- T-A2-3
- Vancocine
- Neutropenia: postmarketing
- Zyprexa Relprevv
- abacavir
- abacavir-lamivudine
- acetaminophen
- actinomycin D
- acyclovir
- albendazole
- Neutropenia: postmarketing
- allopurinol
- amantadine
- amiloride
- Neutropenia: postmarketing
- aminoglutethimide
- amiodarone
- Neutropenia: postmarketing
- amisulpride
- Neutropenia: postmarketing
- amoxicillin
- amprenavir
- anthracycline
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide
- asenapine
- atazanavir
- atovaquone
- auranofin
- axitinib
- azithromycin
- Neutropenia: postmarketing
- aztreonam
- benazepril
- Neutropenia: postmarketing
- benazeprilat
- bendamustine
- bexarotene
- bicalutamide
- boceprevir
- Neutropenia: very common, 10% - 19%
- bortezomib
- bosentan
- Neutropenia: postmarketing
- bosutinib
- busulfan
- cabazitaxel
- cabozantinib
- candesartan
- Neutropenia: postmarketing
- candesartan cilexetil
- Neutropenia: postmarketing
- capecitabine
- captopril
- carbenicillin
- carbimazole
- carboplatin
- cefaclor
- Neutropenia: postmarketing
- cefadroxil
- cefazolin
- Neutropenia: postmarketing
- cefdinir
- Neutropenia: postmarketing
- cefditoren
- cefepime
- Neutropenia: postmarketing
- cefixime
- Neutropenia: postmarketing
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil
- ceftaroline
- ceftazidime
- ceftizoxime
- ceftriaxone
- Neutropenia: postmarketing
- cefuroxime
- Neutropenia: postmarketing
- cefuroxime axetil
- cephalexin
- cephem
- Neutropenia: postmarketing
- chlorambucil
- chloroquine
- cidofovir
- Neutropenia: postmarketing, very common, 24.4% - 43.5%
- cilazapril
- Neutropenia: postmarketing
- cimetidine
- ciprofloxacin
- cladribine
- clarithromycin
- Neutropenia: postmarketing
- clindamycin
- clindamycin phosphate
- clofarabine
- clopidogrel
- Neutropenia: very rare, postmarketing, uncommon
- clozapine
- colchicine
- Neutropenia: postmarketing
- crizotinib
- cytarabine
- dabrafenib
- dalbavancin
- darunavir
- dasatinib
- deferasirox
- Neutropenia: postmarketing
- deferiprone
- delavirdine
- demeclocycline
- dexrazoxane
- diatrizoate
- diazepam
- dicloxacillin
- dimercaptosuccinic acid
- disopyramide
- docetaxel
- Neutropenia: very common, 1% - 95.5%
- dolutegravir
- doripenem
- Neutropenia: postmarketing, uncommon
- doxazosin
- doxorubicin
- Neutropenia: common, very common, 1.6% - 95.8%
- doxycycline
- Neutropenia: postmarketing
- doxycycline calcium
- doxycycline hyclate
- emtricitabine
- Neutropenia: postmarketing, common
- entecavir
- Neutropenia: postmarketing
- eribulin
- erlotinib
- ertapenem
- ethacrynic acid
- ethambutol
- etodolac
- etoposide
- everolimus
- Neutropenia: common, 0% - 46%
- famciclovir
- famotidine
- febuxostat
- fentanyl
- fidaxomicin
- Neutropenia: 1.03% - 2.48%
- flucloxacillin
- fluconazole
- Neutropenia: postmarketing
- fludarabine
- flurbiprofen
- fosamprenavir
- foscarnet
- fosinopril
- fosinoprilat
- fusidic acid
- ganciclovir
- Neutropenia: 11.8% - 25.7%
- gatifloxacin
- gemcitabine
- Neutropenia: very common, 0% - 89%
- haloperidol
- Neutropenia: very rare, postmarketing
- histamine
- hydralazine
- hydroxyurea
- ibuprofen
- idarubicin
- imatinib
- Neutropenia: postmarketing, very common, 0% - 100%
- iopamidol
- ioversol
- irbesartan
- Neutropenia: postmarketing
- irbesartan-hydrochlorothiazide
- irinotecan
- itraconazole
- Neutropenia: postmarketing
- ixabepilone
- lacosamide
- lamivudine
- Neutropenia: uncommon, 3% - 8%
- lamotrigine
- Neutropenia: postmarketing
- lansoprazole
- Neutropenia: postmarketing
- lapatinib
- leflunomide
- lenalidomide
- Neutropenia: postmarketing, very common, 33.4% - 79%
- lercanidipine
- levetiracetam
- Neutropenia: postmarketing
- lincomycin
- linezolid
- lurasidone
- lymecycline
- maraviroc
- mebendazole
- meclofenamate
- melphalan
- memantine
- Neutropenia: postmarketing
- mephenytoin
- meropenem
- Neutropenia: postmarketing
- metformin
- methotrexate
- methysergide
- metoclopramide
- Neutropenia: postmarketing
- metronidazole
- mexiletine
- mianserin
- miconazole
- milnacipran
- Neutropenia: postmarketing
- minocycline
- mirtazapine
- mitotane
- mitoxantrone
- moexiprilat
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- Neutropenia: postmarketing
- nafcillin
- nelarabine
- nelfinavir
- Neutropenia: postmarketing
- nevirapine
- Neutropenia: postmarketing, 8.9% - 9%
- nilotinib
- Neutropenia: very common, 11% - 42%
- norfloxacin
- Neutropenia: postmarketing
- ofatumumab
- ofloxacin
- olanzapine
- Neutropenia: postmarketing, rare, common
- olmesartan
- olsalazine
- omeprazole
- Neutropenia: postmarketing
- oxacillin
- oxaliplatin
- Neutropenia: very common, 0% - 82.2%
- oxcarbazepine
- oxytetracycline
- paclitaxel
- Neutropenia: rare, very common, 3% - 100%
- paliperidone
- pamidronate
- pazopanib
- pemetrexed
- Neutropenia: common, 0% - 58%
- penciclovir
- penicillin
- pentamidine
- perindopril
- perindopril erbumine
- Neutropenia: postmarketing
- perindoprilat
- Neutropenia: postmarketing
- piperacillin
- pixantrone
- pomalidomide
- ponatinib
- posaconazole
- Neutropenia: 3.05% - 16.3%
- Neutropenia aggravated
- pralatrexate
- prednisone
- pregabalin
- procainamide
- propranolol
- quetiapine
- Neutropenia: postmarketing
- quinidine
- rabeprazole
- Neutropenia: postmarketing
- radium
- raltegravir
- raltitrexed
- ramipril
- ranitidine
- rapamycin
- Neutropenia: postmarketing
- regorafenib
- retigabine
- retinoic acid
- Neutropenia: postmarketing
- ribavirin
- Neutropenia: very common, 1% - 40%
- rifabutin
- rifapentine
- rifaximin
- riluzole
- risperidone
- Neutropenia: postmarketing
- ritonavir
- rufinamide
- ruxolitinib
- Neutropenia: very common, 1.9% - 18.7%
- saquinavir
- sodium cromoglycate
- sofosbuvir
- Neutropenia: very common, 0% - 17%
- sorafenib
- Neutropenia: postmarketing, common, 1% - 11%
- stavudine
- Neutropenia: very rare, postmarketing
- stiripentol
- streptozotocin
- sulfamethoxazole
- sulfasalazine
- sulindac
- sunitinib
- Neutropenia: postmarketing, 2%
- tacrolimus
- Neutropenia: postmarketing, uncommon
- tamoxifen
- telithromycin
- temozolomide
- Neutropenia: common, very common, 0% - 4%
- temsirolimus
- teniposide
- terbinafine
- Neutropenia: very rare, postmarketing
- tetracycline
- tetrahydrobiopterin
- thalidomide
- Neutropenia: postmarketing, 0.98% - 42.7%
- thymidine
- tigecycline
- tinidazole
- tipranavir
- Neutropenia: uncommon, 1%
- tofacitinib
- topiramate
- Neutropenia: very rare, postmarketing
- topotecan
- Neutropenia: very common, 1% - 97%
- trabectedin
- trametinib
- trandolapril
- trimethadione
- trimethoprim
- trimethoprim-sulfamethoxazole
- trimetrexate
- Neutropenia: 3.67% - 9.01%
- valganciclovir
- valproate
- valsartan
- vandetanib
- venlafaxine
- Neutropenia: very rare, postmarketing
- vincristine
- vinflunine
- vinorelbine
- vorinostat
- zafirlukast
- zalcitabine
- zanamivir
- zidovudine
- zidovudine/lamivudine
- zoledronic acid
- zuclopenthixol
|
Drugs with this indication
|